An interventional study of TURN-IT exercise program in Parkinson Disease, sponsored by Oregon Health and Science University. Completed at 1 site in United States. Open to participants aged 55 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by Oregon Health and Science University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 36 studies in Parkinson Disease by Oregon Health and Science University — 4 open to participants now, 4 under way, none of them phase 3. Parkinson Disease · Oregon Health and Science University.
Among the 36 studies in Parkinson Disease by Oregon Health and Science University, this one is the 10th largest by enrollment of the 28 interventional ones that give a count, is the only one that started in 2021, is one of 17 with no phase, and was the 32nd registered.
4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.
Browse Parkinson Disease studies →4 of the 36 studies in Parkinson Disease by Oregon Health and Science University are open now, in 2 countries. Recruiting first, the newest first:
Oregon Health and Science University · Sites in United States, Brazil
Ages 50–80
Oregon Health and Science University · Sites in United States
Ages 45–85
Oregon Health and Science University · Sites in United States
Ages 40–90
Oregon Health and Science University · Sites in United States
Ages 55–85
By country, each count listing its studies:
Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.
This study: 55 Years to 85 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
36 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 55 is above the median of 40 across 3,360 interventional studies indexed under Parkinson Disease.
Median enrollment 22 across the 28 interventional studies, 17 across the 8 observational. Of the 26 that completed or were terminated, 10 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
Oregon Health and Science University is the lead sponsor of 697 studies on the registry; 129 are open to participants now.
Of its 53 completed or terminated interventional studies of FDA-regulated products, 39 (74%) have results posted.
3 of the studies in Parkinson Disease by Oregon Health and Science University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06815302Oregon Health and Science UniversityTURN-IT FOG: Improving Turning and Freezing of Gait in People With PD | 2026-12-31 |
| NCT05680597Oregon Health and Science UniversityBalance Tele-Rehab in Parkinson's Disease | 2027-06 |
| NCT05818189Oregon Health and Science UniversityCortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing | 2027-10-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 36 studies in Parkinson Disease by Oregon Health and Science University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this intervention is to explore the effectiveness of a Turning Intervention (TURN-IT) to improve quality of turning in participants with Parkinson's Disease (PD). An unique exercise program has been developed - TURN-IT - in which participants practice exercises that focus on physiological constraints that impair turning ability, such as axial rigidity, narrow base of support, bradykinesia, and inflexible set-shifting. The 60 participants with PD and a history of falls in the previous 12 months, will be randomized into a 6-week, 3x/week, one-on-one TURN-IT group or No-Intervention Control group. This pilot intervention study will determine the number of subjects needed for a future clinical trial and will determine the sensitivity to change with rehabilitation our daily-life turning quality measures (such as, mean and variability of number of steps to turn, turn amplitude, turn velocity). The investigators predict that the TURN-IT program will improve turning in daily life enough to justify a larger clinical trial.
The criteria were revised on the registry on Nov 6, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in the treatment group will attend supervised, 1-hour classes, 3 times per week for 6 weeks, one-on-one with the same exercise trainer, overseen by a physical therapist investigator.
Behavioral: TURN-IT exercise program
Participants in this group will be tested at baseline and 6 weeks later. They will go about their normal daily life during the 6 week period.
Based on the exercise motor learning principles, participants spend 10-15 minutes at each Exercise Station that focuses on particular constraints of turning ability. The stations will focus on important underlying aspects of turning, such as weight-shifting and increasing axial rotation during functional turning tasks. Each station will be progressed across levels to make more challenging (such as adding a dual task). Initially participants will be supported in an overhead body-weight support system (ZeroG) to allow them to practice challenging exercises without the risk of falling.
Variability in Number of Steps to Complete a Turn
The coefficient of variation in the number of steps in a turn, averaged from daily monitoring, as measured at 6 weeks.
Time frame: 6 weeks
Change in Falls Efficacy Scale International
The difference in the Falls Efficacy Scale, as measured at baseline and 6 weeks. The Falls Efficacy Scale is a 16 item self-administered questionnaire to assess fear of falling. Scores range 16-64 with higher score indicating more fear of falling.
Time frame: baseline and 6 weeks
Prospective Fall Incidence
Number of prospective falls recorded for 12 months starting from the end of intervention
Time frame: 52 weeks
Patient Global Impression of Change
Question of participant's rating of mobility. Score range from 1-7 with 1-3 indicating improvement, 4 no change, and 5-7 worsening of mobility. Single score provided at the end of 6 week period.
Time frame: 6 weeks
Number of Steps to Complete a Turn
The number of steps in a turning averaged from daily monitoring, as measured at 6 weeks.
Time frame: 6 weeks
Turn Peak Velocity
Peak velocity of turns averaged from daily monitoring, as measured at 6 weeks.
Time frame: 6 weeks
Turn Angle Amplitude
The peak size of turn angles averaged from daily monitoring, as measured at 6 weeks.
Time frame: 6 weeks
Turn Duration
Time to complete turns averaged from daily monitoring, as measured at 6 weeks.
Time frame: 6 weeks
Variability of Double-support Time
The coefficient of variation in time of double-support phase, as measured at 6 weeks.
Time frame: 6 weeks
Lateral Trunk Range
The range of motion in the trunk during walking, in the lateral direction, as measured at 6 weeks.
Time frame: 6 weeks
Change in Mini-Balance Evaluation Systems Test
The change in mini-Balance Evaluation Systems Test, a clinical measure of four balance domains-anticipatory, reactive, sensory, and dynamic gait, as measured at baseline and 6 weeks. Scores range from 0-28 with higher scores indicating worse balance.
Time frame: baseline and 6 weeks
Clinical Global Impression of Change
Question of clinician's rating of participant mobility. Score range from 1-7 with 1-3 indicating improvement, 4 no change, and 5-7 worsening of mobility. Single score provided at the end of 6 week period.
Time frame: 6 weeks
Change in Parkinson's Disease Questionnaire-39
The difference in the Parkinson's disease questionnaire-39 (PDQ-39) - a 39 item self-report questionnaire to assess Parkinson's disease specific health related quality in eight domains of quality of life - as measured at baseline and 6 weeks. Each item scores from 0 (never) to 4 (always). Sub-scale scores and a Parkinson's Disease summary index (PDSI; sum of eight subsections/8) representing the global health-related quality of life will be calculated, with higher scores representing worse quality of life
Time frame: baseline and 6 weeks
Change in Unified Parkinson's Disease Rating Scale, Part III
Difference in the Unified Parkinson's Disease Rating Scale, Part III (UPDRS-III), as measured at baseline and 6 weeks. The UPDRS-III is a clinical scale to assess severity of motor symptoms in Parkinson's disease. Each item is scored 0 (normal) to 4 (severe) with a score range from 0-132
Time frame: baseline and 6 weeks
Change in Activities-Specific Balance Confidence Scale
The difference in Activities-Specific Balance Confidence (ABC) Scale, as measured at baseline and 6 weeks. The ABC Scale is a 16-item self-report scale that participants rate their confidence in performing daily activities. Score range from 0-100% with 0% meaning no confidence and 100% completely confident
Time frame: baseline and 6 weeks
Stride Velocity
Stride velocity during straight walking averaged from daily monitoring, as measured at 6 weeks.
Time frame: 6 weeks
Stride Length
Stride length during straight walking averaged from daily monitoring, as measured at 6 weeks.
Time frame: 6 weeks
Cadence
The number of straight walking steps taken per minute averaged from daily monitoring, as measured at 6 weeks.
Time frame: 6 weeks
Double Support Time
The amount of time both feet were on the ground together during straight walking averaged from daily monitoring, as measured at 6 weeks.
Time frame: 6 weeks
Angle of Foot at Heel Strike
The angle between the foot and the ground at heel strike during straight walking averaged from daily monitoring, as measured at 6 weeks.
Time frame: 6 weeks
Variability of Angle of Foot at Heel Strike
Coefficient of variation of the angle between the foot and the ground at heel strike during straight walking averaged from daily monitoring, as measured at 6 weeks.
Time frame: 6 weeks
Number of Turns Per Hour
The average number of turns per hour measured during daily monitoring at 6 weeks.
Time frame: 6 weeks
| Milestone | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Started | 27 | 28 |
| Pre-testing | 27 | 25 |
| Completed | 25 | 22 |
| Not completed | 2 | 6 |
| Withdrew: Early termination | 1 | 4 |
| Withdrew: Drop out | 0 | 2 |
| Withdrew: Lost to follow-up | 1 | 0 |
The coefficient of variation in the number of steps in a turn, averaged from daily monitoring, as measured at 6 weeks.
| Coefficient of variation | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Variability in Number of Steps to Complete a Turn | 0.58 (0.57 to 0.59) | 0.57 (0.56 to 0.58) |
The difference in the Falls Efficacy Scale, as measured at baseline and 6 weeks. The Falls Efficacy Scale is a 16 item self-administered questionnaire to assess fear of falling. Scores range 16-64 with higher score indicating more fear of falling.
| change in units on a scale | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Change in Falls Efficacy Scale International | 0.56 (-2.3 to 3.42) | -2.91 (-5.48 to -0.34) |
Number of prospective falls recorded for 12 months starting from the end of intervention
| Falls | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Prospective Fall Incidence | 13.42 (12.01 to 15) | 14.95 (13.36 to 16.73) |
Question of participant's rating of mobility. Score range from 1-7 with 1-3 indicating improvement, 4 no change, and 5-7 worsening of mobility. Single score provided at the end of 6 week period.
| score on a scale | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Patient Global Impression of Change | 4.00 (4.0 to 4.5) | 3.00 (2.00 to 3.00) |
The number of steps in a turning averaged from daily monitoring, as measured at 6 weeks.
| Number of steps (log2) | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Number of Steps to Complete a Turn | 1.69 (1.67 to 1.72) | 1.71 (1.68 to 1.75) |
Peak velocity of turns averaged from daily monitoring, as measured at 6 weeks.
| degrees per second | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Turn Peak Velocity | 86.41 (83.07 to 89.76) | 86.24 (82.81 to 89.66) |
The peak size of turn angles averaged from daily monitoring, as measured at 6 weeks.
| degrees per turn | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Turn Angle Amplitude | 81.62 (80.34 to 82.9) | 82.13 (80.82 to 83.44) |
Time to complete turns averaged from daily monitoring, as measured at 6 weeks.
| seconds | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Turn Duration | 2.46 (2.42 to 2.5) | 2.50 (2.45 to 2.54) |
The coefficient of variation in time of double-support phase, as measured at 6 weeks.
| Coefficient of variation | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Variability of Double-support Time | 0.22 (0.2 to 0.23) | 0.22 (0.21 to 0.23) |
The range of motion in the trunk during walking, in the lateral direction, as measured at 6 weeks.
| log-transformed degrees of motion | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Lateral Trunk Range | 2.55 (2.45 to 2.64) | 2.53 (2.43 to 2.63) |
The change in mini-Balance Evaluation Systems Test, a clinical measure of four balance domains-anticipatory, reactive, sensory, and dynamic gait, as measured at baseline and 6 weeks. Scores range from 0-28 with higher scores indicating worse balance.
| change in units on a scale | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Change in Mini-Balance Evaluation Systems Test | 0.12 (-1.06 to 1.3) | 2.76 (1.54 to 3.98) |
Question of clinician's rating of participant mobility. Score range from 1-7 with 1-3 indicating improvement, 4 no change, and 5-7 worsening of mobility. Single score provided at the end of 6 week period.
| score on a scale | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Clinical Global Impression of Change | 4.00 (3.00 to 4.00) | 4.00 (3.00 to 4.00) |
The difference in the Parkinson's disease questionnaire-39 (PDQ-39) - a 39 item self-report questionnaire to assess Parkinson's disease specific health related quality in eight domains of quality of life - as measured at baseline and 6 weeks. Each item scores from 0 (never) to 4 (always). Sub-scale scores and a Parkinson's Disease summary index (PDSI; sum of eight subsections/8) representing the global health-related quality of life will be calculated, with higher scores representing worse quality of life
| change in units on a scale | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Change in Parkinson's Disease Questionnaire-39 | 3.32 (-0.66 to 7.29) | 2.43 (-1.79 to 6.65) |
Difference in the Unified Parkinson's Disease Rating Scale, Part III (UPDRS-III), as measured at baseline and 6 weeks. The UPDRS-III is a clinical scale to assess severity of motor symptoms in Parkinson's disease. Each item is scored 0 (normal) to 4 (severe) with a score range from 0-132
| change in units on a scale | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Change in Unified Parkinson's Disease Rating Scale, Part III | -1.36 (-4.72 to 2.0) | -3.59 (-6.96 to -0.23) |
The difference in Activities-Specific Balance Confidence (ABC) Scale, as measured at baseline and 6 weeks. The ABC Scale is a 16-item self-report scale that participants rate their confidence in performing daily activities. Score range from 0-100% with 0% meaning no confidence and 100% completely confident
| change in units on a scale | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Change in Activities-Specific Balance Confidence Scale | -0.99 (-5.56 to 3.57) | 6.83 (1.41 to 12.25) |
Stride velocity during straight walking averaged from daily monitoring, as measured at 6 weeks.
| meters per second | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Stride Velocity | 0.89 (0.85 to 0.92) | 0.92 (0.88 to 0.96) |
Stride length during straight walking averaged from daily monitoring, as measured at 6 weeks.
| meters | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Stride Length | 1.02 (0.99 to 1.03) | 1.04 (1.0 to 1.07) |
The number of straight walking steps taken per minute averaged from daily monitoring, as measured at 6 weeks.
| steps per minute | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Cadence | 51.45 (50.72 to 52.18) | 52.46 (51.7 to 53.22) |
The amount of time both feet were on the ground together during straight walking averaged from daily monitoring, as measured at 6 weeks.
| percent time spent in double support | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Double Support Time | 25.46 (24.76 to 26.15) | 24.50 (23.77 to 25.23) |
The angle between the foot and the ground at heel strike during straight walking averaged from daily monitoring, as measured at 6 weeks.
| degrees | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Angle of Foot at Heel Strike | -16.31 (-17.28 to -15.33) | -16.26 (-17.28 to -15.24) |
Coefficient of variation of the angle between the foot and the ground at heel strike during straight walking averaged from daily monitoring, as measured at 6 weeks.
| Coefficient of variation | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Variability of Angle of Foot at Heel Strike | -0.44 (-0.48 to -0.40) | -0.44 (-0.48 to -0.40) |
The average number of turns per hour measured during daily monitoring at 6 weeks.
| turns completed per hour | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| Number of Turns Per Hour | 21.94 (19.56 to 24.31) | 22.47 (20.05 to 24.9) |
Collected over Roughly 8 weeks per participant. Adverse events were tracked from the time a participant signed an informed consent form to join the study to when they finished their post-intervention testing and daily life monitoring.. Non-serious events are listed at a 3% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| No Intervention Control Group | 0/27 (0%) | 0/27 (0%) | 0/27 (0%) |
| TURN-IT Group | 0/28 (0%) | 0/28 (0%) | 3/28 (10.7%) |
| Event | No Intervention Control Group | TURN-IT Group |
|---|---|---|
| COVIDRespiratory, thoracic and mediastinal disorders | 0/27 | 2/28 |
| SciaticaNervous system disorders | 0/27 | 1/28 |
The number of participants assessed at baseline differs from the number analyzed due to participant drop outs and loss to follow up.
| Age, Continuous(years of age) | TURN-IT Group | No Intervention Control Group | Total |
|---|---|---|---|
| Mean | 69.9 ± 5.89 | 70.3 ± 6.67 | 70.1 ± 6.23 |
| Sex: Female, Male(Participants) | TURN-IT Group | No Intervention Control Group | Total |
|---|---|---|---|
| Female | 13 | 11 | 24 |
| Male | 15 | 16 | 31 |
| Ethnicity (NIH/OMB)(Participants) | TURN-IT Group | No Intervention Control Group | Total |
|---|---|---|---|
| Hispanic or Latino | 1 | 0 | 1 |
| Not Hispanic or Latino | 25 | 27 | 52 |
| Unknown or Not Reported | 2 | 0 | 2 |
| Race (NIH/OMB)(Participants) | TURN-IT Group | No Intervention Control Group | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 0 | 0 | 0 |
| White | 27 | 27 | 54 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 1 | 0 | 1 |
| Region of Enrollment(Participants) | TURN-IT Group | No Intervention Control Group | Total |
|---|---|---|---|
| United States | 28 | 27 | 55 |
| Experience Freezing of Gait(Participants) | TURN-IT Group | No Intervention Control Group | Total |
|---|---|---|---|
| Yes | 16 | 17 | 33 |
| No | 12 | 10 | 22 |
| Body Mass Index(kg/m2) | TURN-IT Group | No Intervention Control Group | Total |
|---|---|---|---|
| Mean | 25.0 ± 5.28 | 24.8 ± 3.72 | 24.9 ± 4.54 |
| Years since Parkinson's diagnosis(years) | TURN-IT Group | No Intervention Control Group | Total |
|---|---|---|---|
| Mean | 9.68 ± 7.48 | 11.1 ± 6.42 | 10.4 ± 6.95 |
6 further baseline measures are reported on the registry.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — Upon reasonable request, we can share de-identified data related to study outcomes measures.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Data would be available 6 months after the end of data collection. Data will be stored in our laboratory data repository and so will be available indefinitely.
Access criteria: Data will not be stored on a public website, however researchers may contact us for access to the data. We will send data electronically via a secure server.
Ran from Sep 2021 to primary completion in Jun 2025, 45 months.
Results were first posted in Nov 2026, 1 year 4 months after primary completion.
Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's 45 months is above that.
Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.
Completion moved once since we started tracking on Sep 25, 2026: Jun 2026 → Jul 2026, on Nov 6, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oregon Health and Science University →